Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124

In a significant move, faculty members at the University of Michigan have voted overwhelmingly in favor of a resolution aimed at reinstating gender-affirming care procedures for minors at Michigan Medicine, the university’s medical center. The vote took place on November 3 and highlighted the faculty’s growing concern regarding the ongoing debate around gender-affirming treatments.
The Faculty Senate’s vote recorded 2,432 faculty members in support of the resolution, while 555 opposed it, and 651 abstained. This strong majority signifies a crucial shift in support for transgender minors seeking medical care.
The resolution articulates a striking message regarding the healthcare disparities faced by transgender minors. It emphasizes that withholding necessary medical treatments from these individuals constitutes discrimination. The faculty believes that cisgender individuals under 19 years of age continue to receive various medically necessary healthcare options, including hormone therapies, which creates a disparity detrimental to transgender individuals.
This assertion has stirred debate among advocates and opponents of gender-affirming care. Advocates argue that these procedures are vital for the well-being of transgender minors, while opponents raise concerns about the long-term effects of such treatments.
Michigan Medicine defines gender-affirming care broadly, encompassing medical, surgical, and mental health services tailored for transgender, nonbinary, and gender non-conforming patients. This includes a range of support options designed to affirm patients’ gender identities and meet their unique healthcare needs.
Earlier this year, Michigan Medicine made headlines when it announced plans to discontinue sex-change procedures for minors, which included administering puberty blockers and hormone therapies. This decision, made in August, was influenced by a complex interplay of regulatory changes and public opinion.
Shanna Kattari, an associate professor specializing in social work and women’s studies, attributes the decision to halt gender-affirming procedures for minors to political pressures from the previous administration. Kattari expressed frustration over what she sees as capitulation to harmful demands that lack empirical support.
Standing firmly on her beliefs, Kattari criticized those who she feels have added to the stigma facing transgender minors. She stated, “We have no right to call ourselves the leaders and best, only followers who have bent the knee.” This sentiment reflects broader concerns about the governance of healthcare practices in educational institutions.
In a response to the resolution and ongoing conversations about gender-affirming care, Mary Masson, senior director of public relations at Michigan Medicine, reaffirmed the institution’s commitment to providing comprehensive, multidisciplinary care. She noted, “On August 25, 2025, University of Michigan Health announced it would discontinue gender-affirming hormonal therapies and puberty blocker medications for minors. That is our current position.”
Masson stressed the importance of ensuring that patients and families can make informed decisions, emphasizing the importance of mental health services and support as part of patient care. This approach aims to prioritize the well-being of individuals and their families in challenging circumstances.
The ongoing discussions and resolutions indicate a future where inclusivity and diversity in healthcare are prioritized. The faculty’s vote in support of reinstating gender-affirming treatments may reshape policies at Michigan Medicine and beyond.
Moreover, the discourse on the topic highlights the impact such policies have on marginalized communities, including LGBTQIA2S+ individuals. Advocates continue to emphasize the importance of inclusive health practices that recognize and respond to the unique needs of these populations.
As society grapples with the complexities of gender identity and medical care, the University of Michigan’s faculty resolution serves as a rallying point for discussions on healthcare equity and accessibility. The faculty’s voice underscores a critical demand for a healthcare framework that serves all individuals, regardless of their gender identity.
The recent resolution reflects not only the changing attitudes within academic settings but also signifies a broader societal shift toward acceptance and understanding of gender diversity. As healthcare institutions navigate these evolving discussions, the need for balanced and informed dialogues remains crucial.
With continuing advancements in research and advocacy, healthcare environments can adapt to meet the needs of diverse populations. The University of Michigan is positioning itself as a potential leader in this evolving landscape, demonstrating a commitment to understanding and addressing the needs of transgender minors.
The faculty’s decisive action may inspire other educational institutions to reassess their healthcare policies for adolescents, ultimately fostering a more inclusive approach to medical care. This ongoing conversation will be essential in shaping the future of gender-affirming care not just in Michigan, but across the nation.